Daily Asprin not a good idea says FDA now (image Source The Liberty Beacon)
It's no secret that this blog and its associates are of the opinion that the medical professions are owned by the drug companies and thus their priority is corporate profit rather than patient's wellbeing.
For years many of us, particularly males over 50 have been badgered by our doctors and by government propaganda to take a daily does of asprin to prevent cardio vascular disease. senior health bureaucrats have even lobbied for laws mandating daily asprin.
So why the U turn, is it an admission that yet again, as with salt, as with saturated fats, as with cholestrol lowering drugs, the Big Pharma corporations, governments and their bought and paid for scientists have been peddling lies and junk science again?
via The Liberty Beacon:
FDA Reverses Position On Daily Asprin
If you haven’t had a heart attack, step away from the aspirin bottle… If you are one of the 40 million Americans who take an aspirin every day, you may want to heed the latest warning from the US Food and Drug Administration (FDA).
After many decades of promoting aspirin, the FDA now says that if you have not experienced a heart problem, you should not be taking a daily aspirin—even if you have a family history of heart disease. This represents a significant departure from FDA’s prior position on aspirin for the prevention of heart attacks.
On its website, the FDA now says:
“FDA has concluded that the data do
not support the use of aspirin as a preventive medication by people who
have not had a heart attack, stroke or cardiovascular problems, a use
that is called ‘primary prevention.’ In such people, the benefit has not
been established but risks — such as dangerous bleeding into the brain
or stomach — are still present.”
read original article:
FDA Reverses It's Position On Daily Asprin
RELATED POSTS:The NHS doctors who get cash from healthcare firms for patient referrals
An investigation revealed incentives, often worth tens of thousands of pounds, have been offered to doctors by private healthcare companies in exchange for referring patients to their hospitals. The British Medical Journal reported claims that the doctors’ regulator, the General Medical Council (GMC), failed to act on a warning in 2012 that the practice of offering incentives was “widespread, particularly in London, and significant in value”.
The risk of daily paracetamol
Over prescribing created drug restistant diseases
Mandatory medication? The Great statins scam
